索引于
  • 学术期刊数据库
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Pharmacokinetic Evaluation of Newly Developed Oral Immediate Release and Sustained Release Dosage Forms of Losartan Potassium

Basuvan Babu, Subramania Nainar Meyyanathan, Byran Gowramma, Selvadurai Muralidharan, Kannan Elango and Bhojraj Suresh

The aim of our present study is to develop oral sustained release dosage form for Losartan Potassium (SS) with wet granulation technique. Xanthan gum with additives MCC PH101 was used for the present study. The dissolution study is carried out. The studies indicated that the drug release can be modulated by varying the concentration of the polymer and fillers. The pharmacokinetic parameters including AUC 0–t , AUC 0–∞ , C max , T max , T 1/2 , and elimination rate constant ( K el ) were determined from plasma concentration of both formulations of Immediate Release (Losartan Potassium 1.75 mg tablets) and Sustained Release (Losartan Potassium 3.5 mg tablets). The absorption of drug from the sustained release tablets was significantly higher than that for the reference Losartan Potassium tablet because of longer half-life and lower elimination. Different pharmacokinetic parameters including AUC 0-t , AUC 0-∞ , C max , T max , T 1/2 , and K eli were determined from plasma concentration of both Sustained and Immediate release tablets.